Successful treatment of tofacitinib in a case with rheumatoid arthritis who experienced hepatitis B virus reactivation induced by tocilizumab and recovered from entecavir rescue therapy
Biologics presenting with moderate risk for hepatitis B virus reactivation (HBV-R) were approved as alternative treatment for refractory rheumatoid arthritis (RA).[1] In this article, we report a case with RA who recovered from tocilizumab (TCZ) induced HBV-R by entecavir (ETV) and was successfully...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Turkish Society of Gastroenterology
2021-09-01
|
| Serija: | The Turkish Journal of Gastroenterology |
| Online pristup: | http://avestema.com.dedi9374.your-server.de/index.php/pub/article/view/1204 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|